Dr. Mathew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Rose St, Cc401b
Lexington, KY 40536Phone+1 859-323-8043Fax+1 859-257-7715
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2012 - 2015
University of Kerala Medical CollegeClass of 2006
Certifications & Licensure
KY State Medical License 2015 - 2025
PA State Medical License 2012 - 2016
Publications & Presentations
PubMed
- 73 citationsDistinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast.Aju Mathew, Vipin Villgran, Gurprataap S. Sandhu, Rachel C. Jankowitz, Mini E. Jacob
Geburtshilfe Und Frauenheilkunde. 2017-06-01 - 58 citationsCombined blockade of activating ERBB2 mutations and ER results in synthetic lethality of ER+/HER2 mutant breast cancerSarah Croessmann, Luigi Formisano, Lisa N. Kinch, Paula I. Gonzalez-Ericsson, Dhivya R. Sudhan
Clinical Cancer Research. 2019-01-01 - 72 citationsRecurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancerRyan J. Hartmaier, Sally E. Trabucco, Nolan Priedigkeit, Jon Chung, Christine A. Parachoniak
Annals of Oncology. 2018-04-01
Journal Articles
- Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast CancerAju Mathew, MD, Clinical Cancer Research
Press Mentions
Placebo, Palliative or Prescribed?February 18th, 2023- 30% of New Drugs Approved in India May Be Ineffective: StudyJuly 30th, 2022
- Study Bares Cancer’s Financial BurdenDecember 2nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
